Price: quote on request. Your total cost is quoted in writing per case.
We reply within one business day
Get my quote

Osteoporosis: US-approved treatments and how Gulf families can access them

A plain guide for families in the Gulf, checked against US FDA labels, Gulf drug registers and published medical research.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Osteoporosis: the short answer

The US FDA has approved four medicines on this page for osteoporosis, each for specific patients. Four of them are on at least one Gulf register we checked, so ask your hospital about local supply first. Otherwise the hospital can request a named-patient import. Reserve Meds is a digital health company. We do not diagnose or prescribe.

  • US FDA-approved medicines on this page: Forteo, Tymlos, Evenity and Prolia.
  • Gulf registration (checked 17 October 2026): see each medicine below.
  • Legal route: Local supply where listed; otherwise a named-patient import request filed by the treating hospital.
  • Price: Quote on request.

What is osteoporosis?

Osteoporosis is a disease in which bones become weak and are more likely to break. It develops when the body breaks down more bone than it replaces, so bone mass and structure decline.[1]

It is called a silent disease because it usually causes no symptoms until a bone breaks, most often the hip, spine or wrist. Risk is higher in women, especially after menopause, in people over 50, in people with a slim build and in those with a family history of osteoporosis or fractures.[1]

Treatment aims to prevent fractures. In the US, several medicines are approved for people at high risk of fracture, including bone-building injections and an antibody given twice a year.[2, 3, 4]

Osteoporosis in the Gulf

The osteoporosis societies of Saudi Arabia, the UAE, Bahrain, Oman and Kuwait met in Riyadh in 2019 and published a joint GCC consensus on diagnosing osteoporosis and treating postmenopausal women at risk of fractures.[5]

US FDA-approved medicines for osteoporosis

Each medicine below is approved in the US for a specific group of patients. The wording summarizes the current US label. Your specialist decides whether any of them is right for the patient.

  • Forteo (teriparatide)
    FDA-approved for postmenopausal women with osteoporosis at high risk of fracture, and other groups listed in the label. It is a daily injection under the skin.[2]
    Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
    Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Egypt, Jordan, India, Pakistan
  • Tymlos (abaloparatide)
    FDA-approved for postmenopausal women with osteoporosis at high risk of fracture, and to increase bone density in men with osteoporosis at high risk of fracture. It is a daily injection under the skin.[8]
    Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
    Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, Jordan, India, Pakistan
  • Evenity (romosozumab-aqqg)
    FDA-approved for osteoporosis in postmenopausal women at high risk of fracture. It is given as monthly injections under the skin for 12 doses.[3]
    Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
  • Prolia (denosumab)
    FDA-approved for postmenopausal women and men with osteoporosis at high risk of fracture, and glucocorticoid-induced osteoporosis at high risk of fracture. It is an injection under the skin every 6 months.[4]
    Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]

How families in the Gulf can access these medicines

If the medicine is listed in your country. Ask your specialist and the hospital pharmacy about local supply first. A listing does not mean every hospital stocks the medicine, and another brand of the same medicine may also be registered, but local supply is usually the fastest route and you may not need us.

If it is not registered. The usual legal route is a named-patient request: the treating hospital, on your specialist's written request, asks the national regulator for permission to import the medicine for one patient, using the US FDA approval as the reference. In Saudi Arabia the SFDA Special Access Program guidance covers these requests; in Bahrain, NHRA Circular 41 of 2020 sets the procedure. Other Gulf countries have their own procedures, which the hospital pharmacy confirms.[9, 10] Once approval is in place, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital pharmacy.

Who does what

  • Your treating specialist decides whether a medicine is right for the patient and writes the letter.
  • The hospital checks local supply, files any import request, and gives the treatment safely.
  • The national regulator decides whether to approve the import of a medicine that is not registered.
  • The manufacturer decides where its medicine can be supplied, especially for cell and gene therapies.
  • Reserve Meds helps organize records, coordinates US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.

Documents you will usually need

  • A letter from the treating specialist with the diagnosis, past treatments and why the medicine is being considered
  • Reports that confirm the diagnosis, such as laboratory, genetic, imaging or pathology results, translated into English where needed
  • Recent clinic notes and a list of current medicines
  • For a hospital import request: the prescription, the hospital's request form and the written consent of the patient or guardian
  • Proof of the US FDA approval and the US prescribing information (we can supply these)

We give you a written timeline estimate once we see the hospital file. The regulator, the treatment center and the manufacturer set their own timelines.

What treatment costs

Quote on request. Your total cost depends on the medicine, the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and temperature-controlled shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them.

Ask us about treatment for osteoporosis

Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.

Include the country code, for example +966 or +971.
Message us on WhatsApp

No account needed. We reply within one business day. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

Frequently asked questions

Is there an FDA-approved treatment for osteoporosis?

Yes. The medicines on this page have US FDA approval for specific groups of patients: Forteo, Tymlos, Evenity and Prolia. The exact conditions are in each US label and are summarized above. Your specialist decides whether any of them fits.

Is Forteo available in Saudi Arabia or the UAE?

Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register. A listing in Abu Dhabi does not show federal UAE status.

How can a family in the Gulf get Forteo?

Ask the treating hospital about local supply first. If it is not available, the hospital can file a named-patient import request with the national regulator on your specialist's written request. Once approved, we arrange US supply to the hospital pharmacy.

How much does treatment cost?

Quote on request. Your total cost, including the medicine, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.

Why is osteoporosis called silent?

MedlinePlus explains it usually causes no symptoms, so many people find out only when they break a bone. Bone density testing can find it earlier.

Is there regional guidance in the Gulf?

Yes. GCC osteoporosis societies published a consensus on assessment and treatment of postmenopausal women at fracture risk.

Sources for the last two answers: [1] [5]

Sources

Checked on 17 October 2026. Labels, registers and regulator rules change. Your hospital pharmacy confirms the current position before filing.

  1. MedlinePlus (US National Library of Medicine): Osteoporosis
  2. DailyMed (US National Library of Medicine): Forteo (teriparatide) US prescribing information, version published 19 August 2026
  3. DailyMed (US National Library of Medicine): Evenity (romosozumab-aqqg) US prescribing information, version published 3 August 2026
  4. DailyMed (US National Library of Medicine): Prolia (denosumab) US prescribing information, version published 7 July 2026
  5. Al-Saleh et al. Diagnosis and management of osteoporosis in postmenopausal women in Gulf Cooperation Council (GCC) countries: consensus statement of the GCC countries' osteoporosis societies under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Arch Osteoporos 2020 (PubMed 32700153)
  6. SFDA: Drugs List, public register (all 9,173 entries checked by brand name on 17 October 2026)
  7. Department of Health Abu Dhabi: drug code list Drugs.xlsx (release 26 September 2026, effective 2 October 2026)
  8. DailyMed (US National Library of Medicine): Tymlos (abaloparatide) US prescribing information, version published 17 August 2026
  9. SFDA: Special Access Program (SAP) guidance, version 1.0
  10. NHRA Bahrain: Circular No. (41) of 2020, procedures for importing non-registered medicines and pharmaceutical products

Related

This page is general health information, not medical advice. It does not replace a consultation with your doctor.

WhatsApp